 Methylsulphasalazine rheumatoid arthritis Methylsulphasalazine sulphasalazine addition methyl group benefits parent drug side-effects rheumatoid arthritis RA outcome use RA patients study months therapy adverse effects withdrew reasons unrelated drug treatment inefficacy serious adverse effects significant improvement clinical assessments weeks onwards Significant improvement plasma viscosity trend towards improvement serum CRP histidine IgM concentrations good correlation mean serial changes clinical biochemical assessments drug properties second-line agent Median steady-state serum concentrations methylsulphasalazine methylsulphapyridine micrograms/ml micrograms/ml